Reglan Failure-To-Warn Suit Brought To Supreme Court

Law360, Washington (March 01, 2012, 5:05 PM ET) -- Three individuals who developed a neurological disorder after taking generic versions of heartburn medication Reglan told the U.S. Supreme Court last month that the Hatch-Waxman Amendments should not preempt their state failure-to-warn claims against makers of generic Reglan.

Alice Wilson, Dennis Morris and Lala Smith are appealing the Sixth Circuit's September ruling that a Kentucky federal judge had correctly nixed their suits in 2008 because the claims against the generics makers were preempted by federal law and the claims against the brand-name producers weren't viable under...
To view the full article, register now.